͵͵

Journal News

From the journals: JLR

Anju Duley
By Anju Duley
Aug. 19, 2022

A metabolic role for lipid droplet–mitochondria coupling. A new way to study atherosclerosis in mice. A novel function of a damage response protein. Read about papers on these topics recently published in the Journal of Lipid Research.

 

A metabolic role for lipid droplet–mitochondria coupling

Lipid droplets, or LDs, are dynamic organelles found in eukaryotic cells where fatty acids are stored temporarily in the form of triglycerides — the most common type of fat in our bodies. The phospholipid monolayer of LDs hosts Perilipin 5 protein. This protein, known as PLIN5, is highly expressed in oxidative tissues including skeletal muscle, liver and heart.

Mitochondria (red) and lipid droplets (green) in a mammalian cell loaded with oleic acid.
NICHD/T. Balla
Mitochondria (red) and lipid droplets (green) in a mammalian cell loaded
with oleic acid.

PLIN5 plays an important role in regulating intracellular lipid homeostasis, disruption of which can cause mitochondrial dysfunction and lipotoxicity — damage caused by accumulation of free fatty acids. PLIN5 tightly anchors mitochondria to the LD membrane via its last 20 C-terminal amino acids; this is commonly known as LD-mitochondria coupling or LDMC. Researchers have not established the role of LDMC in intracellular lipid metabolism.

In a recent article in the , Benedikt Kien at the University of Graz Institute of ͵͵ Biosciences in Austria and a team of researchers describe determining the specific role of PLIN5-mediated LDMC in intracellular lipid metabolism by overexpressing a mutant PLIN5 that disrupts LDMC. This mutant PLIN5 lacks the last three C-terminal amino acids.

The mutant PLIN5 did not alter intracellular lipid homeostasis significantly compared with the cells overexpressing the wild-type PLIN5. Various cell lines overexpressing PLIN5 mutant showed a moderate reduction of mitochondrial beta-oxidation compared to wild-type PLIN5. This signifies that LDMC has a very moderate impact on mitochondrial fatty acid oxidation.

The researchers’ study showed that LDMC improves mitochondrial respiration, a process that requires oxygen to produce cellular energy. Also, PLIN5-mediated LDMC protects cells from lipotoxic damage by increasing the rate of fatty acid storage and slowing lipid breakdown in the event of increased cellular fatty acid uptake. LDMC may help mitochondria adapt to an increased demand for this uptake and oxidation as well. The study suggests that LDMC plays a vital role in preserving mitochondrial function, and cell lines overexpressing PLIN5 mutant can be used as models to investigate the effect of LDMC on other cellular functions.

A new way to study atherosclerosis in mice

Gene-editing technology can generate low-density lipoprotein receptor–deficient mice that are used widely for atherosclerosis research. However, such genetically modified mice require rigorous breeding to study atherosclerosis of complex systems. Anti-sense oligonucleotide against low-density lipoprotein receptor, or Ldlr-ASO, can generate complex genetic models to study hypercholesterolemic atherosclerosis in animals without time-consuming breeding procedures. ASOs are single-stranded small oligonucleotides (less than 50 nucleotides) that specifically bind to a complementary mRNA sequence and inhibit the translation of protein corresponding to the ASO-bound mRNA sequence.

In a recent article in the , Diego Gomes at the University of Washington and a team of researchers describe their parallel studies of this form of atherosclerosis in two groups of mice; one group was genetically deficient in Ldlr protein, while the other group had sufficient Ldlr and received Ldlr-ASO. The researchers compared the plasma cholesterol levels, size of the atherosclerotic lesion and the extent of hepatic inflammation between the two groups.

In plasma samples, cholesterol levels in the genetically deficient mice were twice as high as those in the Ldlr-ASO treated mice. Also, male mice from both groups had higher plasma cholesterol than female mice. The genetically deficient mice developed more advanced atherosclerosis as evidenced by larger lesion areas compared to their Ldlr-ASO counterparts. However, mice treated with Ldlr-ASO showed increased hepatic inflammation. Nonetheless, Ldlr-ASO is an effective and efficient strategy to study the early stages of atherosclerotic lesions and complex genetic models of atherosclerosis.

A novel function of a damage response protein

Cytochrome P450 enzymes, or P450s, are a superfamily of heme-containing proteins involved in cellular functions such as biosynthesis of steroid hormones, drug metabolism, cholesterol synthesis and breakdown of xenobiotic compounds. The damage response protein, or Dap1, is a heme-binding protein known to interact with several P450s and regulate P450s involved in ergosterol biosynthesis of yeast. Ergosterol is a steroid alcohol found in the cell membranes of fungi; it functions like cholesterol in animals and is a precursor for vitamin D synthesis. Researchers have found that Dap1 alters the production of ergosterol in yeasts.

In a recent article in the , Ana-Maria Gonzalez and Maximiliano Venegas at the Universidad de Chile and a team of researchers found a new role of Dap1 in carotenoid biosynthesis in the yeast Xanthophyllomyces dendrorhous. This yeast produces astaxanthin, a carotenoid that causes pink-red pigmentation in animals such as salmon, red trout and flamingos. Fisheries use astaxanthin as a dietary supplement and color additive in fish foods.

In this study, the researchers deleted a DAP1 gene in X. dendrorhous, which changed the yeast pigmentation, decreasing astaxanthin and reducing the proportion of ergosterol. This suggests that Dap1 regulates the biosynthesis of astaxanthin and ergosterol in the yeast. By showing the interaction of Dap1 with the P450s involved in the biosynthesis of astaxanthin and ergosterol, the study reveals a new role of Dap1 — the regulation of carotenogenesis. This means Dap1 might be used to enhance the production of astaxanthin in this yeast.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Anju Duley
Anju Duley

Anju Duley earned her Ph.D. in chemistry from the Indian Institute of Technology Kanpur. She is passionate about science communication.

Related articles

From the journals: JLR
Clementine Adeyemi
From the Journals: JLR
Sephra Rampersad
From the journals: JLR
Joseph Heath
From the journals: MCP
Renae Crossing
From the journals: JLR
Meric Ozturk

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.